Banks - Regional
Compare Stocks
5 / 10Stock Comparison
FUNC vs MNSB vs CARE vs FXNC vs NKSH
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
FUNC vs MNSB vs CARE vs FXNC vs NKSH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $248M | $176M | $580M | $253M | $240M |
| Revenue (TTM) | $112M | $136M | $255M | $112M | $85M |
| Net Income (TTM) | $25M | $16M | $31M | $18M | $16M |
| Gross Margin | 68.8% | 54.4% | 61.7% | 74.0% | 65.1% |
| Operating Margin | 24.4% | 14.0% | 15.7% | 19.6% | 22.5% |
| Forward P/E | 8.7x | 10.4x | 4.8x | 11.7x | 11.7x |
| Total Debt | $188M | $70M | $179M | $43M | $2M |
| Cash & Equiv. | $78M | $25M | $105M | $161M | $8M |
FUNC vs MNSB vs CARE vs FXNC vs NKSH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| First United Corpor… (FUNC) | 100 | 277.5 | +177.5% |
| MainStreet Bancshar… (MNSB) | 100 | 177.2 | +77.2% |
| Carter Bankshares, … (CARE) | 100 | 371.0 | +271.0% |
| First National Corp… (FXNC) | 100 | 210.5 | +110.5% |
| National Bankshares… (NKSH) | 100 | 122.4 | +22.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FUNC vs MNSB vs CARE vs FXNC vs NKSH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FUNC ranks third and is worth considering specifically for long-term compounding and valuation efficiency.
- 289.2% 10Y total return vs FXNC's 241.1%
- PEG 0.77 vs FXNC's 7.87
- Lower P/E (8.7x vs 11.7x), PEG 0.77 vs 145.48
MNSB has the current edge in this matchup, primarily because of its strength in quality and efficiency.
- Efficiency ratio 0.4% vs FXNC's 0.5% (lower = leaner)
- Efficiency ratio 0.4% vs FXNC's 0.5%
CARE is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.56, Low D/E 42.5%, current ratio 0.75x
- Beta 0.56 vs NKSH's 0.76
- +69.0% vs MNSB's +26.4%
FXNC is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 11 yrs, beta 0.70, yield 2.2%
- Rev growth 27.1%, EPS growth 96.0%
- NIM 3.6% vs NKSH's 2.5%
- 27.1% NII/revenue growth vs MNSB's -1.4%
NKSH is the clearest fit if your priority is defensive.
- Beta 0.76, yield 4.0%, current ratio 1203.84x
- 4.0% yield, 1-year raise streak, vs FXNC's 2.2%, (2 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 27.1% NII/revenue growth vs MNSB's -1.4% | |
| Value | Lower P/E (8.7x vs 11.7x), PEG 0.77 vs 145.48 | |
| Quality / Margins | Efficiency ratio 0.4% vs FXNC's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.56 vs NKSH's 0.76 | |
| Dividends | 4.0% yield, 1-year raise streak, vs FXNC's 2.2%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +69.0% vs MNSB's +26.4% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs FXNC's 0.5% |
FUNC vs MNSB vs CARE vs FXNC vs NKSH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FUNC vs MNSB vs CARE vs FXNC vs NKSH — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FXNC leads in 1 of 6 categories
NKSH leads 1 • FUNC leads 1 • CARE leads 1 • MNSB leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
FXNC leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CARE is the larger business by revenue, generating $255M annually — 3.0x NKSH's $85M. NKSH is the more profitable business, keeping 18.6% of every revenue dollar as net income compared to MNSB's 11.5%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $112M | $136M | $255M | $112M | $85M |
| EBITDAEarnings before interest/tax | $36M | $23M | $46M | $25M | $20M |
| Net IncomeAfter-tax profit | $25M | $16M | $31M | $18M | $16M |
| Free Cash FlowCash after capex | $16M | $13M | $30M | $21M | $17M |
| Gross MarginGross profit ÷ Revenue | +68.8% | +54.4% | +61.7% | +74.0% | +65.1% |
| Operating MarginEBIT ÷ Revenue | +24.4% | +14.0% | +15.7% | +19.6% | +22.5% |
| Net MarginNet income ÷ Revenue | +18.4% | +11.5% | +12.3% | +15.8% | +18.6% |
| FCF MarginFCF ÷ Revenue | +18.2% | +7.8% | +12.5% | +18.7% | +17.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +20.2% | +120.9% | +8.3% | +7.1% | +91.7% |
Valuation Metrics
Evenly matched — FUNC and MNSB and FXNC each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 12.1x trailing earnings, FUNC trades at a 35% valuation discount to CARE's 18.7x P/E. Adjusting for growth (PEG ratio), FUNC offers better value at 1.08x vs NKSH's 145.48x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $248M | $176M | $580M | $253M | $240M |
| Enterprise ValueMkt cap + debt − cash | $357M | $221M | $654M | $134M | $234M |
| Trailing P/EPrice ÷ TTM EPS | 12.12x | 13.36x | 18.71x | 14.27x | 15.14x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.68x | 10.45x | 4.77x | 11.75x | 11.71x |
| PEG RatioP/E ÷ EPS growth rate | 1.08x | — | — | 9.55x | 145.48x |
| EV / EBITDAEnterprise value multiple | 11.52x | 11.58x | 16.34x | 6.13x | 12.20x |
| Price / SalesMarket cap ÷ Revenue | 2.22x | 1.30x | 2.28x | 2.25x | 2.81x |
| Price / BookPrice ÷ Book value/share | 1.39x | 0.82x | 1.40x | 1.35x | 1.30x |
| Price / FCFMarket cap ÷ FCF | 12.18x | 16.57x | 18.25x | 12.03x | 15.85x |
Profitability & Efficiency
NKSH leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
FUNC delivers a 12.5% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $7 for MNSB. NKSH carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to FUNC's 1.05x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs MNSB's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +12.5% | +7.3% | +7.6% | +10.0% | +9.0% |
| ROA (TTM)Return on assets | +1.2% | +0.7% | +0.7% | +0.9% | +0.9% |
| ROICReturn on invested capital | +5.9% | +5.0% | +5.7% | +7.7% | +8.4% |
| ROCEReturn on capital employed | +8.5% | +0.9% | +1.5% | +9.9% | +1.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 8 | 7 | 8 |
| Debt / EquityFinancial leverage | 1.05x | 0.32x | 0.43x | 0.23x | 0.01x |
| Net DebtTotal debt minus cash | $109M | $45M | $73M | -$118M | -$6M |
| Cash & Equiv.Liquid assets | $78M | $25M | $105M | $161M | $8M |
| Total DebtShort + long-term debt | $188M | $70M | $179M | $43M | $2M |
| Interest CoverageEBIT ÷ Interest expense | 1.01x | 0.31x | 0.39x | 0.84x | 0.64x |
Total Returns (Dividends Reinvested)
FUNC leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in FUNC five years ago would be worth $23,452 today (with dividends reinvested), compared to $12,056 for MNSB. Over the past 12 months, CARE leads with a +69.0% total return vs MNSB's +26.4%. The 3-year compound annual growth rate (CAGR) favors FUNC at 47.1% vs MNSB's 6.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +4.4% | +19.4% | +34.8% | +14.6% | +14.2% |
| 1-Year ReturnPast 12 months | +27.8% | +26.4% | +69.0% | +46.9% | +49.7% |
| 3-Year ReturnCumulative with dividends | +218.6% | +21.5% | +94.7% | +110.8% | +55.1% |
| 5-Year ReturnCumulative with dividends | +134.5% | +20.6% | +87.2% | +68.7% | +31.9% |
| 10-Year ReturnCumulative with dividends | +289.2% | +126.9% | +112.9% | +241.1% | +51.3% |
| CAGR (3Y)Annualised 3-year return | +47.1% | +6.7% | +24.9% | +28.2% | +15.7% |
Risk & Volatility
CARE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CARE is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than NKSH's 0.76 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CARE currently trades 98.5% from its 52-week high vs FUNC's 91.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.72x | 0.66x | 0.56x | 0.70x | 0.76x |
| 52-Week HighHighest price in past year | $41.95 | $25.17 | $26.58 | $29.85 | $40.00 |
| 52-Week LowLowest price in past year | $28.00 | $17.86 | $15.37 | $18.31 | $24.74 |
| % of 52W HighCurrent price vs 52-week peak | +91.0% | +93.4% | +98.5% | +93.7% | +94.3% |
| RSI (14)Momentum oscillator 0–100 | 50.6 | 50.4 | 75.4 | 47.6 | 51.1 |
| Avg Volume (50D)Average daily shares traded | 11K | 58K | 276K | 80K | 50K |
Analyst Outlook
Evenly matched — FXNC and NKSH each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FUNC as "Buy", MNSB as "Hold", CARE as "Buy", FXNC as "Buy", NKSH as "Buy". Consensus price targets imply 3.1% upside for CARE (target: $27) vs -34.5% for FUNC (target: $25). For income investors, NKSH offers the higher dividend yield at 4.01% vs FUNC's 2.15%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $25.00 | — | $27.00 | $21.00 | — |
| # AnalystsCovering analysts | 1 | 1 | 4 | 1 | 4 |
| Dividend YieldAnnual dividend ÷ price | +2.2% | — | — | +2.2% | +4.0% |
| Dividend StreakConsecutive years of raises | 7 | 2 | 0 | 11 | 1 |
| Dividend / ShareAnnual DPS | $0.82 | — | — | $0.61 | $1.51 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.6% | 0.0% | +3.4% | +0.1% | 0.0% |
FXNC leads in 1 of 6 categories (Income & Cash Flow). NKSH leads in 1 (Profitability & Efficiency). 2 tied.
FUNC vs MNSB vs CARE vs FXNC vs NKSH: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FUNC or MNSB or CARE or FXNC or NKSH a better buy right now?
For growth investors, First National Corporation (FXNC) is the stronger pick with 27.
1% revenue growth year-over-year, versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). First United Corporation (FUNC) offers the better valuation at 12. 1x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate First United Corporation (FUNC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FUNC or MNSB or CARE or FXNC or NKSH?
On trailing P/E, First United Corporation (FUNC) is the cheapest at 12.
1x versus Carter Bankshares, Inc. at 18. 7x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: First United Corporation wins at 0. 77x versus National Bankshares, Inc. 's 145. 48x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — FUNC or MNSB or CARE or FXNC or NKSH?
Over the past 5 years, First United Corporation (FUNC) delivered a total return of +134.
5%, compared to +20. 6% for MainStreet Bancshares, Inc. (MNSB). Over 10 years, the gap is even starker: FUNC returned +289. 2% versus NKSH's +51. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FUNC or MNSB or CARE or FXNC or NKSH?
By beta (market sensitivity over 5 years), Carter Bankshares, Inc.
(CARE) is the lower-risk stock at 0. 56β versus National Bankshares, Inc. 's 0. 76β — meaning NKSH is approximately 34% more volatile than CARE relative to the S&P 500. On balance sheet safety, National Bankshares, Inc. (NKSH) carries a lower debt/equity ratio of 1% versus 105% for First United Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — FUNC or MNSB or CARE or FXNC or NKSH?
By revenue growth (latest reported year), First National Corporation (FXNC) is pulling ahead at 27.
1% versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). On earnings-per-share growth, the picture is similar: MainStreet Bancshares, Inc. grew EPS 210. 0% year-over-year, compared to 32. 1% for Carter Bankshares, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FUNC or MNSB or CARE or FXNC or NKSH?
National Bankshares, Inc.
(NKSH) is the more profitable company, earning 18. 6% net margin versus 11. 5% for MainStreet Bancshares, Inc. — meaning it keeps 18. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FUNC leads at 24. 4% versus 14. 0% for MNSB. At the gross margin level — before operating expenses — FXNC leads at 74. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FUNC or MNSB or CARE or FXNC or NKSH more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, First United Corporation (FUNC) is the more undervalued stock at a PEG of 0. 77x versus National Bankshares, Inc. 's 145. 48x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 4. 8x forward P/E versus 11. 7x for First National Corporation — 7. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CARE: 3. 1% to $27. 00.
08Which pays a better dividend — FUNC or MNSB or CARE or FXNC or NKSH?
In this comparison, NKSH (4.
0% yield), FXNC (2. 2% yield), FUNC (2. 2% yield) pay a dividend. MNSB, CARE do not pay a meaningful dividend and should not be held primarily for income.
09Is FUNC or MNSB or CARE or FXNC or NKSH better for a retirement portfolio?
For long-horizon retirement investors, First United Corporation (FUNC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
72), 2. 2% yield, +289. 2% 10Y return). Both have compounded well over 10 years (FUNC: +289. 2%, MNSB: +126. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FUNC and MNSB and CARE and FXNC and NKSH?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: FUNC is a small-cap high-growth stock; MNSB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock; FXNC is a small-cap high-growth stock; NKSH is a small-cap deep-value stock. FUNC, FXNC, NKSH pay a dividend while MNSB, CARE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.